Left Main Coronary Artery Percutaneous Coronary Intervention: Evolution and Results over Time

Left main coronary artery percutaneous coronary intervention (LMCA PCI) is a treatment option that is increasingly used in our setting. One of the reasons for choosing this therapeutic strategy is the improvements in devices and techniques. However, the long-term results of LMCA PCI are not well established.

Angioplastia al tronco de la coronaria izquierda: evolución y resultados en el tiempo

The aim of this retrospective study was to analyze UK data to assess the time trend of LMCA PCI and its clinical outcomes over a 9-year period.

Researchers analyzed 14,522 patients who underwent LMCA PCI between 2009 and 2017 in the UK. Changes in patient demographics were observed, with patients being older and with greater comorbidities. In addition, procedural complexity increased, either with greater number of vessels treated, bifurcation involvement, or greater number of stents used, and greater use of intravascular ultrasound and rotational atherectomy.

After adjustment, there was a significant reduction in the time to occurrence of periprocedural acute myocardial infarction (p < 0.001), in-hospital major cardiac or cerebrovascular events (p < 0.001), and procedural complications (p < 0.001).

Read also: TAVR and New Onset LBBB.

In a multivariate analysis, age, female sex, number of stents, and patient comorbidity were associated with higher rates of in-hospital cardiac or cerebrovascular events. Meanwhile, use intravascular imaging and year of PCI were associated with lower rates of major in-hospital events.

Conclusion

In patients with LMCA PCI, there were significant temporal changes with the increase in age and comorbidities. While the complexity of this intervention increases over the years, the rate of periprocedural acute myocardial infarction, major in-hospital events, and procedural complications decrease significantly over time. This information is of great help to the Heart Time when it comes to decision making regarding choosing a therapeutic strategy.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: Temporal Trends in In-Hospital Outcomes Following Unprotected Left-Main Percutaneous Coronary Intervention: An Analysis of 14522 Cases From British Cardiovascular Intervention Society Database 2009 to 2017.

Reference: Tim Kinnaird et al Circ Cardiovasc Interv. 2023;16:e012350.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...